Official registry condition

Endometriosis peptide trials

4 selected ClinicalTrials.gov records carrying the official condition label Endometriosis. The label is copied from each retained registry version and does not imply that PeptideScanner has verified a diagnosis, treatment relationship, or study result.

Registry records

4 selected records.

Connected peptides

4 profiles.

Registry update years

2008–2024 in selected records.

Indication intelligence

Selected evidence landscape

Trial phases4

Phase labels copied from the retained ClinicalTrials.gov versions.

Registry statuses1

Overall statuses at each retained observation, not necessarily current today.

Across the connected peptide profiles, PeptideScanner also carries 107 selected PubMed records and 14 selected Drugs@FDA applications. Those records are profile context only; PeptideScanner does not claim they concern Endometriosis unless their own cited source says so.

Collection change ledger

Recently changed records on this condition hub

All recent changes →

These events come only from the exact registry records shown on this page. The condition label does not establish a diagnosis, treatment relationship, or scientific agreement.

Record added

ClinicalTrials.gov record NCT00034047

PeptideScanner retained ClinicalTrials.gov record NCT00034047 at 2026-11-16T01:35:57.709Z. Its registry update date was 2008-01-25, and PeptideScanner's reviewed identity mapping was nafarelin.

PeptideScanner change date
November 16, 2026
Cited source date
January 25, 2008
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT00244452

PeptideScanner retained ClinicalTrials.gov record NCT00244452 at 2026-11-15T22:02:39.332Z. Its registry update date was 2008-03-31, and PeptideScanner's reviewed identity mapping was cetrorelix.

PeptideScanner change date
November 15, 2026
Cited source date
March 31, 2008
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT01682642

PeptideScanner retained ClinicalTrials.gov record NCT01682642 at 2026-11-15T21:50:32.222Z. Its registry update date was 2015-03-20, and PeptideScanner's reviewed identity mapping was goserelin.

PeptideScanner change date
November 15, 2026
Cited source date
March 20, 2015
Evidence lane
Clinical trials

Attributed registry records

Selected records

All trial facets →